| Year |
Citation |
Score |
| 2022 |
Ko M, Makena MR, Schiapparelli P, Suarez-Meade P, Mekile AX, Lal B, Lopez-Bertoni H, Kozielski KL, Green JJ, Laterra J, Quiñones-Hinojosa A, Rao R. The endosomal pH regulator NHE9 is a driver of stemness in glioblastoma. Pnas Nexus. 1: pgac013. PMID 35387234 DOI: 10.1093/pnasnexus/pgac013 |
0.309 |
|
| 2022 |
Lopez-Bertoni H, Johnson A, Rui Y, Lal B, Sall S, Malloy M, Coulter JB, Lugo-Fagundo M, Shudir S, Khela H, Caputo C, Green JJ, Laterra J. Sox2 induces glioblastoma cell stemness and tumor propagation by repressing TET2 and deregulating 5hmC and 5mC DNA modifications. Signal Transduction and Targeted Therapy. 7: 37. PMID 35136034 DOI: 10.1038/s41392-021-00857-0 |
0.342 |
|
| 2021 |
Zhan D, Yalcin F, Ma D, Fu Y, Wei S, Lal B, Li Y, Dzaye O, Laterra J, Ying M, Lopez-Bertoni H, Xia S. Targeting UDP-α-d-glucose 6-dehydrogenase alters the CNS tumor immune microenvironment and inhibits glioblastoma growth. Genes & Diseases. 9: 717-730. PMID 35782977 DOI: 10.1016/j.gendis.2021.08.008 |
0.384 |
|
| 2021 |
Zhan D, Ma D, Wei S, Lal B, Fu Y, Eberhart C, Laterra J, Ying M, Li Y, Meeker A, Lopez-Bertoni H, Xia S. Monoallelic IDH1 R132H mutation mediates glioma cell response to anti-cancer therapies via induction of senescence. Molecular Cancer Research : McR. PMID 34348994 DOI: 10.1158/1541-7786.MCR-21-0284 |
0.372 |
|
| 2021 |
Ma D, Zhan D, Fu Y, Wei S, Lal B, Wang J, Li Y, Lopez-Bertoni H, Yalcin F, Dzaye O, Eberhart CG, Laterra J, Wilson MA, Ying M, Xia S. Mutant IDH1 promotes phagocytic function of microglia/macrophages in gliomas by downregulating ICAM1. Cancer Letters. PMID 34098063 DOI: 10.1016/j.canlet.2021.05.038 |
0.333 |
|
| 2021 |
Laterra J, Ma T, Hu C, Lal B, Zhou W, Ma Y, Ying M, Prinos P, Quiñones-Hinojosa A, Lim M, Li Y. Reprogramming transcription factors Oct4 and Sox2 induces a BRD-dependent immunosuppressive transcriptome in GBM-propagating cells. Cancer Research. PMID 33574085 DOI: 10.1158/0008-5472.CAN-20-2489 |
0.344 |
|
| 2020 |
de la Rocha AMA, González-Huarriz M, Guruceaga E, Mihelson N, Tejada-Solís S, Díez-Valle R, Martínez-Vélez N, Fueyo J, Gomez-Manzano C, Alonso MM, Laterra J, López-Bertoni H. miR-425-5p, a SOX2 target, regulates the expression of FOXJ3 and RAB31 and promotes the survival of GSCs. Archives of Clinical and Biomedical Research. 4: 221-238. PMID 32905473 DOI: 10.26502/Acbr.50170100 |
0.374 |
|
| 2020 |
Thummalapalli R, Heumann T, Stein J, Khan S, Priemer DS, Duffield AS, Laterra J, Couzi R, Lim M, Holdhoff M. Hemophagocytic Lymphohistiocytosis Secondary to PD-1 and IDO Inhibition in a Patient with Refractory Glioblastoma. Case Reports in Oncology. 13: 508-514. PMID 32518546 DOI: 10.1159/000507281 |
0.328 |
|
| 2020 |
Lopez-Bertoni H, Kotchetkov IS, Mihelson N, Lal B, Rui Y, Ames H, Lugo-Fagundo M, Guerrero-Cazares H, Quiñones-Hinojosa A, Green JJ, Laterra J. A Sox2/miR-486-5p axis regulates survival of GBM cells by inhibiting tumor suppressor networks. Cancer Research. PMID 32094299 DOI: 10.1158/0008-5472.Can-19-1624 |
0.412 |
|
| 2020 |
Xu Q, Hu C, Zhu Y, Wang K, Lal B, Li L, Tang J, Wei S, Huang G, Xia S, Lv S, Laterra J, Jiang Y, Li Y. ShRNA-based POLD2 expression knockdown Sensitizes Glioblastoma to DNA-Damaging Therapeutics. Cancer Letters. PMID 31954770 DOI: 10.1016/J.Canlet.2020.01.011 |
0.453 |
|
| 2019 |
Xia S, Ma D, Liu S, Lal B, Wei S, Wang S, Zhan D, Zhang H, Lee RS, Gao P, Lopez-Bertoni H, Ying M, Li JJ, Laterra J, Wilson MA. Extracellular matrix protein tenascin C increases phagocytosis mediated by CD47 loss of function in glioblastoma. Cancer Research. PMID 30898840 DOI: 10.1158/0008-5472.Can-18-3125 |
0.428 |
|
| 2019 |
Xu X, Xu J, Knutsson L, Liu J, Liu H, Li Y, Lal B, Laterra J, Artemov D, Liu G, van Zijl PCM, Chan KWY. The effect of the mTOR inhibitor rapamycin on glucoCEST signal in a preclinical model of glioblastoma. Magnetic Resonance in Medicine. PMID 30793789 DOI: 10.1002/Mrm.27683 |
0.354 |
|
| 2019 |
Sudhir S, Lopez-Bertoni H, Lugo-Fagundo M, Lal B, Laterra J. Abstract 829: SOX2-mediated 5hmC dysregulation in GBM stem cells Cancer Research. 79: 829-829. DOI: 10.1158/1538-7445.Am2019-829 |
0.48 |
|
| 2018 |
Sehgal AA, Li Y, Lal B, Yadav NN, Xu X, Xu J, Laterra J, van Zijl PCM. CEST MRI of 3-O-methyl-D-glucose uptake and accumulation in brain tumors. Magnetic Resonance in Medicine. PMID 30206994 DOI: 10.1002/Mrm.27489 |
0.313 |
|
| 2018 |
Lopez-Bertoni H, Kozielski K, Rui Y, Lal B, Vaughan H, Wilson D, Mihelson N, Eberhart C, Laterra J, Green JJ. Bioreducible polymeric nanoparticles containing multiplexed cancer stem cell-regulating miRNAs inhibit glioblastoma growth and prolong survival. Nano Letters. PMID 29927251 DOI: 10.1021/Acs.Nanolett.8B00390 |
0.359 |
|
| 2018 |
Oyinlade O, Wei S, Lal B, Laterra J, Zhu H, Goodwin CR, Wang S, Ma D, Wan J, Xia S. Targeting UDP-α-D-glucose 6-dehydrogenase inhibits glioblastoma growth and migration. Oncogene. PMID 29479058 DOI: 10.1038/s41388-018-0138-y |
0.534 |
|
| 2018 |
Kotchetkov I, Lopez-Berotni H, Michelson N, Rui Y, Lal B, Li Y, Green J, Laterra J. STEM-23. miR-486-5p REGULATES TUMOR SUPPRESSOR NETWORKS AND ITS INHIBITION REDUCES TUMOR VOLUME AND SENSITIZES TO RADIATION TREATMENT IN A PDX MOUSE MODEL OF GBM Neuro-Oncology. 20: vi248-vi248. DOI: 10.1093/Neuonc/Noy148.1030 |
0.386 |
|
| 2017 |
Coulter JB, Lopez-Bertoni H, Kuhns KJ, Lee RS, Laterra J, Bressler JP. TET1 deficiency attenuates the DNA damage response and promotes resistance to DNA damaging agents. Epigenetics. 0. PMID 28758831 DOI: 10.1080/15592294.2017.1359452 |
0.325 |
|
| 2017 |
Xu Q, Wang K, Ahsan S, Rodriguez F, Eberhart C, Jiang Y, Laterra J, Li Y. Abstract 1471: miR-148a-3p regulation of OTX2 and PRC2 in group 3 and 4 medulloblastoma Cancer Research. 77: 1471-1471. DOI: 10.1158/1538-7445.Am2017-1471 |
0.311 |
|
| 2017 |
de la Rocha AMA, Lopez-Bertoni H, Martínez-Vélez N, Guruceaga E, González-Huarriz M, Laterra J, Roldán MMA. STEM-39. TRANSCRIPTOME ANALYSIS OF GLIOMA STEM-LIKE CELLS REVEALS SOX2 REGULATES miR-425-5p EXPRESSION Neuro-Oncology. 19: vi234-vi234. DOI: 10.1093/Neuonc/Nox168.953 |
0.33 |
|
| 2016 |
Goodwin CR, Woodard CL, Zhou X, Pan J, Olivi A, Xia S, Bettegowda C, Sciubba DM, Pevsner J, Zhu H, Laterra J. Microarray-Based Phospho-Proteomic Profiling of Complex Biological Systems. Translational Oncology. 9: 124-9. PMID 27084428 DOI: 10.1016/J.Tranon.2016.02.001 |
0.522 |
|
| 2016 |
Tilghman J, Schiapparelli P, Lal B, Ying M, Quinones-Hinojosa A, Xia S, Laterra J. Regulation of Glioblastoma Tumor-Propagating Cells by the Integrin Partner Tetraspanin CD151. Neoplasia (New York, N.Y.). 18: 185-98. PMID 26992919 DOI: 10.1016/J.Neo.2016.02.003 |
0.304 |
|
| 2016 |
Lopez-Bertoni H, Lal B, Michelson N, Guerrero-Cázares H, Quiñones-Hinojosa A, Li Y, Laterra J. Epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells. Oncogene. PMID 26898758 DOI: 10.1038/Onc.2016.22 |
0.317 |
|
| 2016 |
Sun H, Luo L, Lal B, Ma X, Chen L, Hann CL, Fulton AM, Leahy DJ, Laterra J, Li M. A monoclonal antibody against KCNK9 K(+) channel extracellular domain inhibits tumour growth and metastasis. Nature Communications. 7: 10339. PMID 26842342 DOI: 10.1038/Ncomms10339 |
0.375 |
|
| 2016 |
Goodwin CR, Liang L, Abu-Bonsrah N, Hdeib A, Elder BD, Kosztowski T, Bettegowda C, Laterra J, Burger P, Sciubba DM. Extraneural Glioblastoma Multiforme Vertebral Metastasis. World Neurosurgery. 89: 578-582.e3. PMID 26704201 DOI: 10.1016/J.Wneu.2015.11.061 |
0.484 |
|
| 2016 |
de la Rocha AMA, Lopez-Bertoni H, Martínez-Vélez N, González-Huarriz M, Laterra J, Roldán MMA. STMC-11. ANALYSIS OF miRNA EXPRESSION PROFILE REGULATED BY SOX2 IN GLIOMA STEM-LIKE CELLS Neuro-Oncology. 18: vi185-vi185. DOI: 10.1093/Neuonc/Now212.775 |
0.324 |
|
| 2015 |
Lopez-Bertoni H, Li Y, Laterra J. Cancer Stem Cells: Dynamic Entities in an Ever-Evolving Paradigm. Biology and Medicine (Aligarh). 7. PMID 27158195 DOI: 10.4172/0974-8369.1000S2-001 |
0.429 |
|
| 2015 |
Xia S, Lal B, Tung B, Wang S, Goodwin CR, Laterra J. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation. Neuro-Oncology. PMID 26320116 DOI: 10.1093/neuonc/nov171 |
0.541 |
|
| 2015 |
Lee EJ, Rath P, Liu J, Ryu D, Pei L, Noonepalle SK, Shull AY, Feng Q, Litofsky NS, Miller DC, Anthony DC, Kirk MD, Laterra J, Deng L, Xin HB, et al. Identification of Global DNA Methylation Signatures in Glioblastoma-Derived Cancer Stem Cells. Journal of Genetics and Genomics = Yi Chuan Xue Bao. 42: 355-71. PMID 26233891 DOI: 10.1016/J.Jgg.2015.06.003 |
0.371 |
|
| 2015 |
Sun H, Luo L, Lal B, Laterra J, Li M. Abstract 640: Probing the tumorigenic properties of two pore potassium channels using inhibitory anti-KCNK9 mAbs Cancer Research. 75: 640-640. DOI: 10.1158/1538-7445.Am2015-640 |
0.375 |
|
| 2015 |
Xia S, Song Q, Wan J, Su Y, Zheng Y, Song H, Qian J, Laterra J, Zhu H. Abstract 2863: DNA methylation dictates transcription factor binding and gene activation in brain tumor Cancer Research. 75: 2863-2863. DOI: 10.1158/1538-7445.Am2015-2863 |
0.34 |
|
| 2015 |
Lopez-Bertoni H, Lal B, Michelson N, Laterra J. EPIG-12EPIGENETIC MODULATION OF A miR-296-5p:HMGA1 AXIS REGULATES THE GLIOBLASTOMA STEM CELL PHENOTYPE Neuro-Oncology. 17: v88.4-v89. DOI: 10.1093/Neuonc/Nov214.12 |
0.446 |
|
| 2015 |
Sun H, Luo L, Lal B, Ma X, Chen L, Fulton A, Leahy D, Laterra J, Li M. ATPS-82PROBING THE TUMORIGENIC PROPERTIES OF TWO PORE POTASSIUM CHANNELS USING INHIBITORY KCNK9 mAbs Neuro-Oncology. 17: v36.3-v36. DOI: 10.1093/Neuonc/Nov204.82 |
0.439 |
|
| 2014 |
Lopez-Bertoni H, Lal B, Li A, Caplan M, Guerrero-Cázares H, Eberhart CG, Quiñones-Hinojosa A, Glas M, Scheffler B, Laterra J, Li Y. DNMT-dependent suppression of microRNA regulates the induction of GBM tumor-propagating phenotype by Oct4 and Sox2. Oncogene. PMID 25328136 DOI: 10.1038/Onc.2014.334 |
0.456 |
|
| 2014 |
Ying M, Tilghman J, Wei Y, Guerrero-Cazares H, Quinones-Hinojosa A, Ji H, Laterra J. Kruppel-like factor-9 (KLF9) inhibits glioblastoma stemness through global transcription repression and integrin α6 inhibition. The Journal of Biological Chemistry. 289: 32742-56. PMID 25288800 DOI: 10.1074/Jbc.M114.588988 |
0.4 |
|
| 2014 |
Sun P, Xia S, Lal B, Shi X, Yang KS, Watkins PA, Laterra J. Lipid metabolism enzyme ACSVL3 supports glioblastoma stem cell maintenance and tumorigenicity. Bmc Cancer. 14: 401. PMID 24893952 DOI: 10.1186/1471-2407-14-401 |
0.427 |
|
| 2014 |
Tilghman J, Wu H, Sang Y, Shi X, Guerrero-Cazares H, Quinones-Hinojosa A, Eberhart CG, Laterra J, Ying M. HMMR maintains the stemness and tumorigenicity of glioblastoma stem-like cells. Cancer Research. 74: 3168-79. PMID 24710409 DOI: 10.1158/0008-5472.Can-13-2103 |
0.47 |
|
| 2014 |
Tilghman J, Laterra J, Ying M. Abstract 3014: Hyaluronan-mediated motility receptor maintains stemness and tumorigenic potential of glioblastoma stem cells Cancer Research. 74: 3014-3014. DOI: 10.1158/1538-7445.Am2014-3014 |
0.468 |
|
| 2014 |
Wang S, Lal B, Tung B, Laterra J, Xia S. Abstract 1973: Influences of extracellular matrix protein tenascin-c on glioblastoma stem cell growth and invasion through tumor-microenvironment interactions Cancer Research. 74: 1973-1973. DOI: 10.1158/1538-7445.Am2014-1973 |
0.514 |
|
| 2014 |
Laterra J, Lopez-Bertoni H, Lal B, Li A, Caplan M, Guerrero-Cazares H, Eberhart CG, Quinones-Hinojosa A, Li Y. EPIGENETIC REGULATION OF GBM CELL STEMNESS AND TUMOR PROPAGATING CAPACITY BY OCT4 AND SOX2 Neuro-Oncology. 16: iii15-iii15. DOI: 10.1093/Neuonc/Nou206.54 |
0.462 |
|
| 2013 |
Woodard CL, Goodwin CR, Wan J, Xia S, Newman R, Hu J, Zhang J, Hayward SD, Qian J, Laterra J, Zhu H. Profiling the dynamics of a human phosphorylome reveals new components in HGF/c-Met signaling. Plos One. 8: e72671. PMID 24023761 DOI: 10.1371/Journal.Pone.0072671 |
0.468 |
|
| 2013 |
Rath P, Lal B, Ajala O, Li Y, Xia S, Kim J, Laterra J. In Vivo c-Met Pathway Inhibition Depletes Human Glioma Xenografts of Tumor-Propagating Stem-Like Cells. Translational Oncology. 6: 104-11. PMID 23556031 DOI: 10.1593/Tlo.13127 |
0.509 |
|
| 2012 |
Rosca EV, Lal B, Koskimaki JE, Popel AS, Laterra J. Collagen IV and CXC chemokine-derived antiangiogenic peptides suppress glioma xenograft growth. Anti-Cancer Drugs. 23: 706-12. PMID 22495619 DOI: 10.1097/Cad.0B013E3283531041 |
0.357 |
|
| 2012 |
Wu Y, Richard JP, Wang SD, Rath P, Laterra J, Xia S. Regulation of glioblastoma multiforme stem-like cells by inhibitor of DNA binding proteins and oligodendroglial lineage-associated transcription factors. Cancer Science. 103: 1028-37. PMID 22380883 DOI: 10.1111/J.1349-7006.2012.02260.X |
0.432 |
|
| 2012 |
Wang SD, Rath P, Lal B, Richard JP, Li Y, Goodwin CR, Laterra J, Xia S. EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase. Oncogene. 31: 5132-43. PMID 22310282 DOI: 10.1038/onc.2012.16 |
0.589 |
|
| 2012 |
Li Y, Laterra J. Cancer stem cells: distinct entities or dynamically regulated phenotypes? Cancer Research. 72: 576-80. PMID 22298594 DOI: 10.1158/0008-5472.Can-11-3070 |
0.412 |
|
| 2012 |
Wang S, Chen Y, Lal B, Ford E, Tryggestad E, Armour M, Yan K, Laterra J, Zhou J. Evaluation of radiation necrosis and malignant glioma in rat models using diffusion tensor MR imaging. Journal of Neuro-Oncology. 107: 51-60. PMID 21948114 DOI: 10.1007/S11060-011-0719-X |
0.308 |
|
| 2012 |
Wang SD, Rath P, Lal B, Richard J, Li YL, Goodwin CR, Laterra J, Xia S. Abstract 4311: EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase Cancer Research. 72: 4311-4311. DOI: 10.1158/1538-7445.Am2012-4311 |
0.501 |
|
| 2012 |
Ying M, Tilghman J, Laterra J. Abstract 3476: Hyaluronan-mediated motility receptor as a novel target for inhibiting glioblastoma stem cells Cancer Research. 72: 3476-3476. DOI: 10.1158/1538-7445.Am2012-3476 |
0.487 |
|
| 2011 |
Goodwin CR, Lal B, Ho S, Woodard CL, Zhou X, Taeger A, Xia S, Laterra J. PTEN reconstitution alters glioma responses to c-Met pathway inhibition. Anti-Cancer Drugs. 22: 905-12. PMID 21654317 DOI: 10.1097/Cad.0B013E3283484750 |
0.556 |
|
| 2011 |
Li Y, Li A, Glas M, Lal B, Ying M, Sang Y, Xia S, Trageser D, Guerrero-Cázares H, Eberhart CG, Quiñones-Hinojosa A, Scheffler B, Laterra J. c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype. Proceedings of the National Academy of Sciences of the United States of America. 108: 9951-6. PMID 21628563 DOI: 10.1073/Pnas.1016912108 |
0.334 |
|
| 2011 |
Ying M, Wang S, Sang Y, Sun P, Lal B, Goodwin CR, Guerrero-Cazares H, Quinones-Hinojosa A, Laterra J, Xia S. Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition. Oncogene. 30: 3454-67. PMID 21383690 DOI: 10.1038/Onc.2011.58 |
0.582 |
|
| 2011 |
Ying M, Sang Y, Li Y, Guerrero-Cazares H, Quinones-Hinojosa A, Vescovi AL, Eberhart CG, Xia S, Laterra J. Krüppel-like family of transcription factor 9, a differentiation-associated transcription factor, suppresses Notch1 signaling and inhibits glioblastoma-initiating stem cells. Stem Cells (Dayton, Ohio). 29: 20-31. PMID 21280156 DOI: 10.1002/Stem.561 |
0.482 |
|
| 2011 |
Zhou J, Tryggestad E, Wen Z, Lal B, Zhou T, Grossman R, Wang S, Yan K, Fu DX, Ford E, Tyler B, Blakeley J, Laterra J, van Zijl PC. Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nature Medicine. 17: 130-4. PMID 21170048 DOI: 10.1038/Nm.2268 |
0.341 |
|
| 2011 |
Bhang HE, Gabrielson KL, Laterra J, Fisher PB, Pomper MG. Tumor-specific imaging through progression elevated gene-3 promoter-driven gene expression. Nature Medicine. 17: 123-9. PMID 21151140 DOI: 10.1038/Nm.2269 |
0.352 |
|
| 2011 |
Rath P, Lal B, Mughal S, Kim KJ, Laterra J. Abstract 3309: Inhibiting c-Met activation depletes glioblastomas of stem-like tumor-initiating cells Cancer Research. 71: 3309-3309. DOI: 10.1158/1538-7445.Am2011-3309 |
0.515 |
|
| 2011 |
Ying M, Sang Y, Li Y, Guerrero-Cazares H, Quinones-Hinojosa A, Vescovi AL, Eberhart CG, Xia S, Laterra J. Abstract 3296: KLF9, a differentiation-associated transcription factor, suppresses Notch1 signaling and inhibits glioblastoma-initiating stem cells Cancer Research. 71: 3296-3296. DOI: 10.1158/1538-7445.Am2011-3296 |
0.495 |
|
| 2010 |
Coon V, Laukert T, Pedone CA, Laterra J, Kim KJ, Fults DW. Molecular therapy targeting Sonic hedgehog and hepatocyte growth factor signaling in a mouse model of medulloblastoma. Molecular Cancer Therapeutics. 9: 2627-36. PMID 20807782 DOI: 10.1158/1535-7163.Mct-10-0486 |
0.412 |
|
| 2010 |
Goodwin CR, Laterra J. Neuro-oncology: unmasking the multiforme in glioblastoma. Nature Reviews. Neurology. 6: 304-5. PMID 20531430 DOI: 10.1038/Nrneurol.2010.67 |
0.546 |
|
| 2010 |
Jansen T, Tyler B, Mankowski JL, Recinos VR, Pradilla G, Legnani F, Laterra J, Olivi A. FasL gene knock-down therapy enhances the antiglioma immune response. Neuro-Oncology. 12: 482-9. PMID 20406899 DOI: 10.1093/Neuonc/Nop052 |
0.465 |
|
| 2010 |
Goodwin CR, Lal B, Zhou X, Ho S, Xia S, Taeger A, Murray J, Laterra J. Cyr61 mediates hepatocyte growth factor-dependent tumor cell growth, migration, and Akt activation. Cancer Research. 70: 2932-41. PMID 20233866 DOI: 10.1158/0008-5472.Can-09-3570 |
0.637 |
|
| 2010 |
Fan S, Meng Q, Laterra JJ, Rosen EM. Scatter factor protects tumor cells against apoptosis caused by TRAIL. Anti-Cancer Drugs. 21: 10-24. PMID 19823077 DOI: 10.1097/Cad.0B013E32832Afc3B |
0.334 |
|
| 2010 |
Chaichana KL, McGirt MJ, Laterra J, Olivi A, Quiñones-Hinojosa A. Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas. Journal of Neurosurgery. 112: 10-7. PMID 19361270 DOI: 10.3171/2008.10.Jns08608 |
0.337 |
|
| 2010 |
Ying M, Xia S, Laterra J. Abstract 5159: Kruppel-like factor 9 modulates the growth and differentiation of glioblastoma-derived neoplastic stem cells Cancer Research. 70: 5159-5159. DOI: 10.1158/1538-7445.Am10-5159 |
0.466 |
|
| 2010 |
Ying M, Sang Y, Lal B, Sun P, Laterra J, Xia S. Abstract 5158: Differentiation of glioblastoma stem-like cells induced by retinoic acid Cancer Research. 70: 5158-5158. DOI: 10.1158/1538-7445.Am10-5158 |
0.325 |
|
| 2010 |
Li Y, Lal B, Cázares HG, Quinones-Hinjosa A, Eberhart C, Laterra J. Abstract 4285: C-Met signaling supports a stem-like transcriptional program and phenotype in glioblastoma Cancer Research. 70: 4285-4285. DOI: 10.1158/1538-7445.Am10-4285 |
0.487 |
|
| 2009 |
Pei Z, Sun P, Huang P, Lal B, Laterra J, Watkins PA. Acyl-CoA synthetase VL3 knockdown inhibits human glioma cell proliferation and tumorigenicity. Cancer Research. 69: 9175-82. PMID 19920185 DOI: 10.1158/0008-5472.Can-08-4689 |
0.495 |
|
| 2009 |
Rudin CM, Hann CL, Laterra J, Yauch RL, Callahan CA, Fu L, Holcomb T, Stinson J, Gould SE, Coleman B, LoRusso PM, Von Hoff DD, de Sauvage FJ, Low JA. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. The New England Journal of Medicine. 361: 1173-8. PMID 19726761 DOI: 10.1056/Nejmoa0902903 |
0.399 |
|
| 2009 |
Li Y, Rory Goodwin C, Sang Y, Rosen EM, Laterra J, Xia S. Camptothecin and Fas receptor agonists synergistically induce medulloblastoma cell death: ROS-dependent mechanisms. Anti-Cancer Drugs. 20: 770-8. PMID 19633536 DOI: 10.1097/Cad.0B013E32832Fe472 |
0.33 |
|
| 2009 |
Lal B, Goodwin CR, Sang Y, Foss CA, Cornet K, Muzamil S, Pomper MG, Kim J, Laterra J. EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts. Molecular Cancer Therapeutics. 8: 1751-60. PMID 19584231 DOI: 10.1158/1535-7163.Mct-09-0188 |
0.608 |
|
| 2009 |
Zhang Y, Byun Y, Ren YR, Liu JO, Laterra J, Pomper MG. Identification of inhibitors of ABCG2 by a bioluminescence imaging-based high-throughput assay Cancer Research. 69: 5867-5875. PMID 19567678 DOI: 10.1158/0008-5472.Can-08-4866 |
0.307 |
|
| 2009 |
Sun P, Xia S, Lal B, Eberhart CG, Quinones-Hinojosa A, Maciaczyk J, Matsui W, Dimeco F, Piccirillo SM, Vescovi AL, Laterra J. DNER, an epigenetically modulated gene, regulates glioblastoma-derived neurosphere cell differentiation and tumor propagation. Stem Cells (Dayton, Ohio). 27: 1473-86. PMID 19544453 DOI: 10.1002/Stem.89 |
0.505 |
|
| 2009 |
Zhang Y, Laterra J, Pomper MG. Hedgehog pathway inhibitor HhAntag691 is a potent inhibitor of ABCG2/BCRP and ABCB1/Pgp. Neoplasia (New York, N.Y.). 11: 96-101. PMID 19107236 DOI: 10.1593/Neo.81264 |
0.404 |
|
| 2008 |
Reardon DA, Cloughsey TF, Raizer JJ, Laterra J, Schiff D, Yang X, Loh E, Wen PY. Phase II study of AMG 102, a fully human neutralizing antibody against hepatocyte growth factor/scatter factor, in patients with recurrent glioblastoma multiforme. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 2051. PMID 27948095 DOI: 10.1200/Jco.2008.26.15_Suppl.2051 |
0.347 |
|
| 2008 |
Li Y, Fan X, Goodwin CR, Laterra J, Xia S. Hepatocyte growth factor enhances death receptor-induced apoptosis by up-regulating DR5. Bmc Cancer. 8: 325. PMID 18992144 DOI: 10.1186/1471-2407-8-325 |
0.582 |
|
| 2008 |
Yi JM, Tsai HC, Glöckner SC, Lin S, Ohm JE, Easwaran H, James CD, Costello JF, Riggins G, Eberhart CG, Laterra J, Vescovi AL, Ahuja N, Herman JG, Schuebel KE, et al. Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors. Cancer Research. 68: 8094-103. PMID 18829568 DOI: 10.1158/0008-5472.Can-07-6208 |
0.355 |
|
| 2008 |
Binning MJ, Niazi T, Pedone CA, Lal B, Eberhart CG, Kim KJ, Laterra J, Fults DW. Hepatocyte growth factor and sonic Hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth. Cancer Research. 68: 7838-45. PMID 18829539 DOI: 10.1158/0008-5472.Can-08-1899 |
0.486 |
|
| 2008 |
Zhou J, Blakeley JO, Hua J, Kim M, Laterra J, Pomper MG, van Zijl PC. Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 60: 842-9. PMID 18816868 DOI: 10.1002/Mrm.21712 |
0.385 |
|
| 2008 |
Li Y, Guessous F, Kwon S, Kumar M, Ibidapo O, Fuller L, Johnson E, Lal B, Hussaini I, Bao Y, Laterra J, Schiff D, Abounader R. PTEN has tumor-promoting properties in the setting of gain-of-function p53 mutations. Cancer Research. 68: 1723-31. PMID 18339852 DOI: 10.1158/0008-5472.Can-07-1963 |
0.324 |
|
| 2008 |
Reznik TE, Sang Y, Ma Y, Abounader R, Rosen EM, Xia S, Laterra J. Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor. Molecular Cancer Research : McR. 6: 139-50. PMID 18234969 DOI: 10.1158/1541-7786.Mcr-07-0236 |
0.376 |
|
| 2008 |
Li Y, Guessous F, Johnson EB, Eberhart CG, Li XN, Shu Q, Fan S, Lal B, Laterra J, Schiff D, Abounader R. Functional and molecular interactions between the HGF/c-Met pathway and c-Myc in large-cell medulloblastoma. Laboratory Investigation; a Journal of Technical Methods and Pathology. 88: 98-111. PMID 18059365 DOI: 10.1038/Labinvest.3700702 |
0.397 |
|
| 2008 |
Salhotra A, Lal B, Laterra J, Sun PZ, van Zijl PC, Zhou J. Amide proton transfer imaging of 9L gliosarcoma and human glioblastoma xenografts. Nmr in Biomedicine. 21: 489-97. PMID 17924591 DOI: 10.1002/Nbm.1216 |
0.36 |
|
| 2008 |
Cornet K, Lal B, Goodwin C, Laterra J. Systemic Delivery of Anti-HGF Monoclonal Antibody Inhibits Glioma Growth Through Downstream Oncogenic Signaling Molecules Planta Medica. 74. DOI: 10.1055/S-2008-1075233 |
0.501 |
|
| 2007 |
Zhang J, van Zijl PC, Laterra J, Salhotra A, Lal B, Mori S, Zhou J. Unique patterns of diffusion directionality in rat brain tumors revealed by high-resolution diffusion tensor MRI. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 58: 454-62. PMID 17763344 DOI: 10.1002/Mrm.21371 |
0.334 |
|
| 2007 |
Xia S, Li Y, Rosen EM, Laterra J. Ribotoxic stress sensitizes glioblastoma cells to death receptor induced apoptosis: requirements for c-Jun NH2-terminal kinase and Bim. Molecular Cancer Research : McR. 5: 783-92. PMID 17699104 DOI: 10.1158/1541-7786.Mcr-06-0433 |
0.354 |
|
| 2007 |
Gerber DE, Laterra J. Emerging monoclonal antibody therapies for malignant gliomas. Expert Opinion On Investigational Drugs. 16: 477-94. PMID 17371196 DOI: 10.1517/13543784.16.4.477 |
0.322 |
|
| 2007 |
Xu J, Gao M, Fan S, Meng Q, Goldberg ID, Abounader R, Ressom H, Laterra JJ, Rosen EM. Effect of Akt inhibition on scatter factor-regulated gene expression in DU-145 human prostate cancer cells. Oncogene. 26: 2925-38. PMID 17099727 DOI: 10.1038/Sj.Onc.1210088 |
0.323 |
|
| 2006 |
Xia S, Laterra J. Hepatocyte growth factor increases mitochondrial mass in glioblastoma cells. Biochemical and Biophysical Research Communications. 345: 1358-64. PMID 16730650 DOI: 10.1016/J.Bbrc.2006.05.064 |
0.333 |
|
| 2006 |
Kim KJ, Wang L, Su YC, Gillespie GY, Salhotra A, Lal B, Laterra J. Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 1292-8. PMID 16489086 DOI: 10.1158/1078-0432.Ccr-05-1793 |
0.448 |
|
| 2005 |
Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy. Cancer Research. 65: 9355-62. PMID 16230398 DOI: 10.1158/0008-5472.Can-05-1946 |
0.514 |
|
| 2005 |
Abounader R, Laterra J. Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis. Neuro-Oncology. 7: 436-51. PMID 16212809 DOI: 10.1215/S1152851705000050 |
0.403 |
|
| 2005 |
Beckner ME, Gobbel GT, Abounader R, Burovic F, Agostino NR, Laterra J, Pollack IF. Glycolytic glioma cells with active glycogen synthase are sensitive to PTEN and inhibitors of PI3K and gluconeogenesis. Laboratory Investigation; a Journal of Technical Methods and Pathology. 85: 1457-70. PMID 16170333 DOI: 10.1038/Labinvest.3700355 |
0.392 |
|
| 2005 |
Lal B, Xia S, Abounader R, Laterra J. Targeting the c-Met pathway potentiates glioblastoma responses to gamma-radiation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 4479-86. PMID 15958633 DOI: 10.1158/1078-0432.Ccr-05-0166 |
0.399 |
|
| 2005 |
Xia S, Rosen EM, Laterra J. Sensitization of glioma cells to Fas-dependent apoptosis by chemotherapy-induced oxidative stress. Cancer Research. 65: 5248-55. PMID 15958570 DOI: 10.1158/0008-5472.Can-04-4332 |
0.326 |
|
| 2004 |
Abounader R, Reznik T, Colantuoni C, Martinez-Murillo F, Rosen EM, Laterra J. Regulation of c-Met-dependent gene expression by PTEN. Oncogene. 23: 9173-82. PMID 15516982 DOI: 10.1038/Sj.Onc.1208146 |
0.409 |
|
| 2004 |
Madden SL, Cook BP, Nacht M, Weber WD, Callahan MR, Jiang Y, Dufault MR, Zhang X, Zhang W, Walter-Yohrling J, Rouleau C, Akmaev VR, Wang CJ, Cao X, St Martin TB, ... ... Laterra J, et al. Vascular gene expression in nonneoplastic and malignant brain. The American Journal of Pathology. 165: 601-8. PMID 15277233 DOI: 10.1016/S0002-9440(10)63324-X |
0.439 |
|
| 2004 |
Hossain MA, Russell JC, Miknyoczki S, Ruggeri B, Lal B, Laterra J. Vascular endothelial growth factor mediates vasogenic edema in acute lead encephalopathy. Annals of Neurology. 55: 660-7. PMID 15122706 DOI: 10.1002/Ana.20065 |
0.309 |
|
| 2004 |
Su W, Gutmann DH, Perry A, Abounader R, Laterra J, Sherman LS. CD44-independent hepatocyte growth factor/c-Met autocrine loop promotes malignant peripheral nerve sheath tumor cell invasion in vitro. Glia. 45: 297-306. PMID 14730703 DOI: 10.1002/Glia.10340 |
0.425 |
|
| 2003 |
Zhou J, Lal B, Wilson DA, Laterra J, van Zijl PC. Amide proton transfer (APT) contrast for imaging of brain tumors. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 50: 1120-6. PMID 14648559 DOI: 10.1002/Mrm.10651 |
0.324 |
|
| 2003 |
Herynk MH, Stoeltzing O, Reinmuth N, Parikh NU, Abounader R, Laterra J, Radinsky R, Ellis LM, Gallick GE. Down-regulation of c-Met inhibits growth in the liver of human colorectal carcinoma cells. Cancer Research. 63: 2990-6. PMID 12782608 |
0.318 |
|
| 2002 |
Hossain MA, Russell JC, Gomez R, Laterra J, Gomes R. Neuroprotection by scatter factor/hepatocyte growth factor and FGF-1 in cerebellar granule neurons is phosphatidylinositol 3-kinase/akt-dependent and MAPK/CREB-independent. Journal of Neurochemistry. 81: 365-78. PMID 12064484 DOI: 10.1046/J.1471-4159.2002.00837.X |
0.327 |
|
| 2002 |
Walter KA, Hossain MA, Luddy C, Goel N, Reznik TE, Laterra J. Scatter factor/hepatocyte growth factor stimulation of glioblastoma cell cycle progression through G(1) is c-Myc dependent and independent of p27 suppression, Cdk2 activation, or E2F1-dependent transcription. Molecular and Cellular Biology. 22: 2703-15. PMID 11909963 DOI: 10.1128/Mcb.22.8.2703-2715.2002 |
0.376 |
|
| 2002 |
Abounader R, Lal B, Luddy C, Koe G, Davidson B, Rosen EM, Laterra J. In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 16: 108-10. PMID 11729097 DOI: 10.1096/Fj.01-0421Fje |
0.487 |
|
| 2001 |
Bouton CM, Hossain MA, Frelin LP, Laterra J, Pevsner J. Microarray analysis of differential gene expression in lead-exposed astrocytes. Toxicology and Applied Pharmacology. 176: 34-53. PMID 11578147 DOI: 10.1006/Taap.2001.9274 |
0.305 |
|
| 2000 |
Hossain MA, Bouton CM, Pevsner J, Laterra J. Induction of vascular endothelial growth factor in human astrocytes by lead. Involvement of a protein kinase C/activator protein-1 complex-dependent and hypoxia-inducible factor 1-independent signaling pathway. The Journal of Biological Chemistry. 275: 27874-82. PMID 10882716 DOI: 10.1074/Jbc.M002185200 |
0.36 |
|
| 2000 |
Guerin C, Luddy C, Abounader R, Lal B, Laterra J. Glioma inhibition by HGF/NK2, an antagonist of scatter factor/hepatocyte growth factor. Biochemical and Biophysical Research Communications. 273: 287-93. PMID 10873600 DOI: 10.1006/Bbrc.2000.2935 |
0.423 |
|
| 1999 |
Lamszus K, Laterra J, Westphal M, Rosen EM. Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas International Journal of Developmental Neuroscience. 17: 517-530. PMID 10571413 DOI: 10.1016/S0736-5748(99)00008-8 |
0.479 |
|
| 1999 |
Abounader R, Ranganathan S, Lal B, Fielding K, Book A, Dietz H, Burger P, Laterra J. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression Journal of the National Cancer Institute. 91: 1548-1556. PMID 10491431 DOI: 10.1093/Jnci/91.18.1548 |
0.341 |
|
| 1999 |
Book AA, Ranganathan S, Abounader R, Rosen E, Laterra J. Scatter factor/hepatocyte growth factor gene transfer increases rat blood-glioma barrier permeability Brain Research. 833: 173-180. PMID 10375692 DOI: 10.1016/S0006-8993(99)01527-9 |
0.436 |
|
| 1999 |
Book AA, Fielding KE, Kundu N, Wilson MA, Fulton AM, Laterra J. IL-10 gene transfer to intracranial 9L glioma: tumor inhibition and cooperation with IL-2. Journal of Neuroimmunology. 92: 50-9. PMID 9916879 DOI: 10.1016/S0165-5728(98)00172-6 |
0.314 |
|
| 1998 |
Hossain MA, Fielding KE, Trescher WH, Ho T, Wilson MA, Laterra J. Human FGF-1 gene delivery protects against quinolinate-induced striatal and hippocampal injury in neonatal rats European Journal of Neuroscience. 10: 2490-2499. PMID 9767380 DOI: 10.1046/J.1460-9568.1998.00259.X |
0.337 |
|
| 1998 |
Lamszus K, Schmidt NO, Jin L, Laterra J, Zagzag D, Way D, Witte M, Weinand M, Goldberg ID, Westphal M, Rosen EM. Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells. International Journal of Cancer. Journal International Du Cancer. 75: 19-28. PMID 9426685 DOI: 10.1002/(Sici)1097-0215(19980105)75:1<19::Aid-Ijc4>3.0.Co;2-4 |
0.424 |
|
| 1997 |
Laterra J, Rosen E, Nam M, Ranganathan S, Fielding K, Johnston P. Scatter factor/hepatocyte growth factor expression enhances human glioblastoma tumorigenicity and growth Biochemical and Biophysical Research Communications. 235: 743-747. PMID 9207232 DOI: 10.1006/Bbrc.1997.6853 |
0.397 |
|
| 1997 |
Guerin C, Laterra J. Regulation of angiogenesis in malignant gliomas. Exs. 79: 47-64. PMID 9002220 DOI: 10.1007/978-3-0348-9006-9_4 |
0.329 |
|
| 1997 |
Nam M, Johnston P, Lal B, Indurti R, Wilson MA, Laterra J. Endothelial cell-based cytokine gene delivery inhibits 9L glioma growth in vivo. Brain Research. 731: 161-70. PMID 8883866 DOI: 10.1016/0006-8993(96)00471-4 |
0.432 |
|
| 1996 |
Johnston P, Nam M, Hossain MA, Indurti RR, Mankowski JL, Wilson MA, Laterra J. Delivery of human fibroblast growth factor-1 gene to brain by modified rat brain endothelial cells. Journal of Neurochemistry. 67: 1643-52. PMID 8858949 DOI: 10.1046/J.1471-4159.1996.67041643.X |
0.389 |
|
| 1996 |
Rosen EM, Laterra J, Joseph A, Jin L, Fuchs A, Way D, Witte M, Weinand M, Goldberg ID. Scatter factor expression and regulation in human glial tumors. International Journal of Cancer. Journal International Du Cancer. 67: 248-55. PMID 8760595 DOI: 10.1002/(Sici)1097-0215(19960717)67:2<248::Aid-Ijc16>3.0.Co;2-7 |
0.447 |
|
| 1994 |
Arosarena O, Guerin C, Brem H, Laterra J. Endothelial differentiation in intracerebral and subcutaneous experimental gliomas. Brain Research. 640: 98-104. PMID 8004469 DOI: 10.1016/0006-8993(94)91861-9 |
0.431 |
|
| 1994 |
Lal B, Indurti RR, Couraud PO, Goldstein GW, Laterra J. Endothelial cell implantation and survival within experimental gliomas. Proceedings of the National Academy of Sciences of the United States of America. 91: 9695-9. PMID 7937875 DOI: 10.1073/Pnas.91.21.9695 |
0.426 |
|
| 1993 |
Laterra J, Indurti RR, Goldstein GW. Plasminogen activation and astroglial-induced neural microvessel morphogenesis. Advances in Experimental Medicine and Biology. 331: 189-99. PMID 8333333 DOI: 10.1007/978-1-4615-2920-0_30 |
0.363 |
|
| 1993 |
Wolff JE, Guerin C, Laterra J, Bressler J, Indurti RR, Brem H, Goldstein GW. Dexamethasone reduces vascular density and plasminogen activator activity in 9L rat brain tumors. Brain Research. 604: 79-85. PMID 7681348 DOI: 10.1016/0006-8993(93)90354-P |
0.438 |
|
| 1992 |
Guerin C, Laterra J, Masnyk T, Golub LM, Brem H. Selective endothelial growth inhibition by tetracyclines that inhibit collagenase. Biochemical and Biophysical Research Communications. 188: 740-745. PMID 1445318 DOI: 10.1016/0006-291X(92)91118-A |
0.361 |
|
| 1992 |
Laterra J, Bressler JP, Indurti RR, Belloni-Olivi L, Goldstein GW. Inhibition of astroglia-induced endothelial differentiation by inorganic lead: a role for protein kinase C. Proceedings of the National Academy of Sciences of the United States of America. 89: 10748-52. PMID 1438272 DOI: 10.1073/Pnas.89.22.10748 |
0.374 |
|
| 1992 |
Wolff JE, Laterra J, Goldstein GW. Steroid inhibition of neural microvessel morphogenesis in vitro: receptor mediation and astroglial dependence. Journal of Neurochemistry. 58: 1023-32. PMID 1371144 DOI: 10.1111/J.1471-4159.1992.Tb09357.X |
0.387 |
|
| 1990 |
Laterra J, Guerin C, Goldstein GW. Astrocytes induce neural microvascular endothelial cells to form capillary-like structures in vitro. Journal of Cellular Physiology. 144: 204-15. PMID 2380251 DOI: 10.1002/Jcp.1041440205 |
0.361 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2022 |
Johnson AL, Laterra J, Lopez-Bertoni H. Exploring glioblastoma stem cell heterogeneity: Immune microenvironment modulation and therapeutic opportunities. Frontiers in Oncology. 12: 995498. PMID 36212415 DOI: 10.3389/fonc.2022.995498 |
0.3 |
|
| 2003 |
Jiang WG, Grimshaw D, Martin TA, Davies G, Parr C, Watkins G, Lane J, Abounader R, Laterra J, Mansel RE. Reduction of stromal fibroblast-induced mammary tumor growth, by retroviral ribozyme transgenes to hepatocyte growth factor/scatter factor and its receptor, c-MET. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 4274-81. PMID 14519655 |
0.299 |
|
| 2012 |
Zhang Y, Pullambhatla M, Laterra J, Pomper MG. Influence of bioluminescence imaging dynamics by D-luciferin uptake and efflux mechanisms. Molecular Imaging. 11: 499-506. PMID 23084250 DOI: 10.2310/7290.2012.00005 |
0.294 |
|
| 2011 |
Blakeley JO, Ye X, Lim M, Zhu H, Blair L, Quinones-Hinojosa A, Eberhart C, Barker P, Laterra J, van Zijl PC, Zhou J. The role of amide proton transfer imaging in detecting active malignant glioma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 2024. PMID 28023846 DOI: 10.1200/Jco.2011.29.15_Suppl.2024 |
0.292 |
|
| 2013 |
Zhou J, Zhu H, Lim M, Blair L, Quinones-Hinojosa A, Messina SA, Eberhart CG, Pomper MG, Laterra J, Barker PB, van Zijl PC, Blakeley JO. Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement. Journal of Magnetic Resonance Imaging : Jmri. 38: 1119-28. PMID 23440878 DOI: 10.1002/Jmri.24067 |
0.291 |
|
| 1981 |
Laterra J, Ansbacher R, Culp LA. Glycosaminoglycans that bind cold-insoluble globulin in cell-substratum adhesion sites of murine fibroblasts. Proceedings of the National Academy of Sciences of the United States of America. 77: 6662-6. PMID 6256752 DOI: 10.1073/Pnas.77.11.6662 |
0.289 |
|
| 2001 |
Abounader R, Ranganathan S, Kim BYS, Nichols C, Laterra J. Signaling pathways in the induction of c-met receptor expression by its ligand scatter factor/hepatocyte growth factor in human glioblastoma Journal of Neurochemistry. 76: 1497-1508. PMID 11238734 DOI: 10.1046/J.1471-4159.2001.00158.X |
0.289 |
|
| 2015 |
Xu X, Chan KW, Knutsson L, Artemov D, Xu J, Liu G, Kato Y, Lal B, Laterra J, McMahon MT, van Zijl PC. Dynamic glucose enhanced (DGE) MRI for combined imaging of blood-brain barrier break down and increased blood volume in brain cancer. Magnetic Resonance in Medicine. PMID 26404120 DOI: 10.1002/Mrm.25995 |
0.287 |
|
| 2018 |
Lopez H, Kozielski KL, Rui Y, Lal B, Vaughan H, Wilson DR, Mihelson N, Eberhart CG, Green JJ, Laterra J. CADD-04. NANOPARTICLE DELIVERY OF miRNAs TO INHIBIT GBM STEM CELLS Neuro-Oncology. 20: vi277-vi277. DOI: 10.1093/Neuonc/Noy148.1153 |
0.285 |
|
| 1999 |
Mankowski JL, Queen SE, Kirstein LM, Spelman JP, Laterra J, Simpson IA, Adams RJ, Clements JE, Zink MC. Alterations in blood-brain barrier glucose transport in SIV-infected macaques Journal of Neurovirology. 5: 695-702. PMID 10602410 DOI: 10.3109/13550289909021298 |
0.275 |
|
| 2018 |
Xue Y, Zhan X, Sun S, Karuppagounder SS, Xia S, Dawson VL, Dawson TM, Laterra J, Zhang J, Ying M. Synthetic mRNAs Drive Highly Efficient iPS Cell Differentiation to Dopaminergic Neurons. Stem Cells Translational Medicine. PMID 30387318 DOI: 10.1002/Sctm.18-0036 |
0.275 |
|
| 2004 |
Abounader R, Montgomery R, Dietz H, Laterra J. Design and expression of chimeric U1/ribozyme transgenes. Methods in Molecular Biology (Clifton, N.J.). 252: 209-19. PMID 15017051 DOI: 10.1385/1-59259-746-7:209 |
0.274 |
|
| 2017 |
Lopez-Bertoni H, Michelson N, Kotchetkov I, Li Y, Laterra J. STEM-38. SOX2 ACTIVATES THE EXPRESSION OF ONCO-miR-486-5p Neuro-Oncology. 19: vi234-vi234. DOI: 10.1093/Neuonc/Nox168.952 |
0.273 |
|
| 2018 |
Tung B, Ma D, Wang S, Oyinlade O, Laterra J, Ying M, Lv SQ, Wei S, Xia S. Krüppel-like factor 9 and histone deacetylase inhibitors synergistically induce cell death in glioblastoma stem-like cells. Bmc Cancer. 18: 1025. PMID 30348136 DOI: 10.1186/S12885-018-4874-8 |
0.272 |
|
| 2023 |
Kamson DO, Puri S, Sang Y, Shi MJ, Blair L, Blakeley JO, Laterra J. Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase (IDH) mutant Astrocytic and Oligodendroglial Tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 37382607 DOI: 10.1158/1078-0432.CCR-23-0585 |
0.263 |
|
| 1992 |
Guerin C, Wolff JE, Laterra J, Drewes LR, Brem H, Goldstein GW. Vascular differentiation and glucose transporter expression in rat gliomas: effects of steroids. Annals of Neurology. 31: 481-7. PMID 1596083 DOI: 10.1002/Ana.410310504 |
0.261 |
|
| 2014 |
Sagal J, Zhan X, Xu J, Tilghman J, Karuppagounder SS, Chen L, Dawson VL, Dawson TM, Laterra J, Ying M. Proneural transcription factor Atoh1 drives highly efficient differentiation of human pluripotent stem cells into dopaminergic neurons. Stem Cells Translational Medicine. 3: 888-98. PMID 24904172 DOI: 10.5966/Sctm.2013-0213 |
0.261 |
|
| 2000 |
Fan S, Ma YX, Wang JA, Yuan RQ, Meng Q, Cao Y, Laterra JJ, Goldberg ID, Rosen EM. The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3' kinase Oncogene. 19: 2212-2223. PMID 10822371 |
0.261 |
|
| 2019 |
Xu X, Sehgal AA, Yadav NN, Laterra J, Blair L, Blakeley J, Seidemo A, Coughlin JM, Pomper MG, Knutsson L, van Zijl PCM. d-glucose weighted chemical exchange saturation transfer (glucoCEST)-based dynamic glucose enhanced (DGE) MRI at 3T: early experience in healthy volunteers and brain tumor patients. Magnetic Resonance in Medicine. PMID 31872916 DOI: 10.1002/Mrm.28124 |
0.258 |
|
| 2015 |
Lopez-Bertoni H, Laterra J. The cancer stem cell phenotype: You can't win until you learn how to lose it. Molecular & Cellular Oncology. 2: e989760. PMID 27308470 DOI: 10.4161/23723556.2014.989760 |
0.258 |
|
| 1997 |
Rosen EM, Lamszus K, Laterra J, Polverini PJ, Rubin JS, Goldberg ID. HGF/SF in angiogenesis. Ciba Foundation Symposium. 212: 215-26; discussion 2. PMID 9524773 DOI: 10.1002/9780470515457.CH14 |
0.258 |
|
| 2012 |
Brognaro E, Ghods A, Feinstein D, Glick R, Connolly KJ, Meetze K, Boudrow A, Gyuris J, Han M, Hingtgen S, Figueiredo J, Farrar C, Farrar C, Deubgen M, Martinez-Quintanilla J, ... ... Laterra JJ, et al. LAB-TUMOR MODELS (IN VIVO/IN VITRO) Neuro-Oncology. 14: vi160-vi164. DOI: 10.1093/Neuonc/Nos241 |
0.257 |
|
| 2009 |
Fan S, Meng Q, Laterra JJ, Rosen EM. Role of Src signal transduction pathways in scatter factor-mediated cellular protection. The Journal of Biological Chemistry. 284: 7561-77. PMID 19047046 DOI: 10.1074/Jbc.M807497200 |
0.256 |
|
| 2004 |
Liang H, O'Reilly S, Liu Y, Abounader R, Laterra J, Maher VM, McCormick JJ. Sp1 regulates expression of MET, and ribozyme-induced down-regulation of MET in fibrosarcoma-derived human cells reduces or eliminates their tumorigenicity. International Journal of Oncology. 24: 1057-67. PMID 15067326 DOI: 10.3892/Ijo.24.5.1057 |
0.252 |
|
| 2009 |
Roda RH, Gallia GL, Eberhart CG, Weingart JD, Laterra J. Epilepsy and temporal lobe injury after skull base proton beam therapy. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 16: 1220-1. PMID 19576784 DOI: 10.1016/J.Jocn.2009.04.003 |
0.251 |
|
| 2019 |
Ma D, Liu S, Lal B, Laterra J, Wilson MA, Xia S. Abstract 5166: Extracellular matrix protein tenascin C increases phagocytosis mediated by CD47 loss-of-function in glioblastoma Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-5166 |
0.251 |
|
| 2009 |
McGirt MJ, Than KD, Weingart JD, Chaichana KL, Attenello FJ, Olivi A, Laterra J, Kleinberg LR, Grossman SA, Brem H, Quiñones-Hinojosa A. Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. Journal of Neurosurgery. 110: 583-8. PMID 19046047 DOI: 10.3171/2008.5.17557 |
0.248 |
|
| 2018 |
Ames HM, Rooper LM, Laterra JJ, Eberhart CG, Rodriguez FJ. INSM1 Expression Is Frequent in Primary Central Nervous System Neoplasms but Not in the Adult Brain Parenchyma. Journal of Neuropathology and Experimental Neurology. PMID 29490065 DOI: 10.1093/Jnen/Nly014 |
0.247 |
|
| 2003 |
Lucey BP, Tihan T, Pomper MG, Olivi A, Laterra J. Spinal meningioma causing diffuse leptomeningeal enhancement. Neurology. 60: 350-1. PMID 12552066 DOI: 10.1212/01.Wnl.0000044052.79677.A9 |
0.246 |
|
| 1994 |
Laterra J, Indurti RR, Goldstein GW. Regulation of in vitro glia-induced microvessel morphogenesis by urokinase. Journal of Cellular Physiology. 158: 317-24. PMID 8106568 DOI: 10.1002/JCP.1041580214 |
0.243 |
|
| 2005 |
Dilmanian FA, Qu Y, Liu S, Cool CD, Gilbert J, Hainfeld JF, Kruse CA, Laterra J, Lenihan D, Nawrocky MM, Pappas G, Sze CI, Yuasa T, Zhong N, Zhong Z, et al. X-ray microbeams: Tumor therapy and central nervous system research. Nuclear Instruments & Methods in Physics Research. Section a, Accelerators, Spectrometers, Detectors and Associated Equipment. 548: 30-37. PMID 17369874 DOI: 10.1016/j.nima.2005.03.062 |
0.243 |
|
| 2005 |
Fan S, Gao M, Meng Q, Laterra JJ, Symons MH, Coniglio S, Pestell RG, Goldberg ID, Rosen EM. Role of NF-kappaB signaling in hepatocyte growth factor/scatter factor-mediated cell protection. Oncogene. 24: 1749-66. PMID 15688034 DOI: 10.1038/Sj.Onc.1208327 |
0.242 |
|
| 2016 |
Michelson N, Lopez-Bertoni H, Li Y, Laterra J. STMC-12. Sox2 ACTIVATES THE EXPRESSION OF ONCO-miRNA-486-5p Neuro-Oncology. 18: vi185-vi185. DOI: 10.1093/Neuonc/Now212.776 |
0.238 |
|
| 2021 |
Gao M, Fu Y, Zhou W, Gui G, Lal B, Li Y, Xia S, Ji H, Eberhart CG, Laterra J, Ying M. EGFR Activates a TAZ-driven Oncogenic Program in Glioblastoma. Cancer Research. PMID 33910930 DOI: 10.1158/0008-5472.CAN-20-2773 |
0.236 |
|
| 2021 |
Kolar EA, Shi X, Clay EM, Moser AB, Lal B, Nirujogi RS, Pandey A, Bandaru VVR, Laterra J, Pei Z, Watkins PA. Very long-chain acyl-CoA synthetase 3 mediates onco-sphingolipid metabolism in malignant glioma. Medical Research Archives. 9. PMID 34395855 DOI: 10.18103/mra.v9i5.2433 |
0.235 |
|
| 2006 |
Ma Y, Yuan RQ, Fan S, Hu C, Goldberg ID, Laterra JJ, Rosen EM. Identification of genes that modulate sensitivity of U373MG glioblastoma cells to cis-platinum. Anti-Cancer Drugs. 17: 733-51. PMID 16926624 DOI: 10.1097/01.Cad.0000217429.67455.18 |
0.234 |
|
| 2010 |
Chaichana KL, Kosztowski T, Niranjan A, Olivi A, Weingart JD, Laterra J, Brem H, Quiñones-Hinojosa A. Prognostic significance of contrast-enhancing anaplastic astrocytomas in adults. Journal of Neurosurgery. 113: 286-92. PMID 20302391 DOI: 10.3171/2010.2.Jns091010 |
0.233 |
|
| 2016 |
Staedtke V, Bai RY, Laterra J. Investigational New Drugs for Brain Cancer. Expert Opinion On Investigational Drugs. PMID 27170161 DOI: 10.1080/13543784.2016.1182497 |
0.231 |
|
| 2015 |
Song X, Xu J, Xia S, Yadav NN, Lal B, Laterra J, Bulte JW, van Zijl PC, McMahon MT. Multi-echo length and offset VARied saturation (MeLOVARS) method for improved CEST imaging. Magnetic Resonance in Medicine. 73: 488-96. PMID 25516490 DOI: 10.1002/Mrm.25567 |
0.23 |
|
| 1991 |
Laterra J, Goldstein GW. Astroglial-induced in vitro angiogenesis: requirements for RNA and protein synthesis. Journal of Neurochemistry. 57: 1231-9. PMID 1716663 DOI: 10.1111/j.1471-4159.1991.tb08284.x |
0.222 |
|
| 1989 |
Fulton AM, Laterra JJ, Hanchin CM. Prostaglandin E2 receptor heterogeneity and dysfunction in mammary tumor cells. Journal of Cellular Physiology. 139: 93-9. PMID 2540214 DOI: 10.1002/JCP.1041390114 |
0.215 |
|
| 2019 |
Heo HY, Xu X, Jiang S, Zhao Y, Keupp J, Redmond KJ, Laterra J, van Zijl PCM, Zhou J. Prospective acceleration of parallel RF transmission-based 3D chemical exchange saturation transfer imaging with compressed sensing. Magnetic Resonance in Medicine. PMID 31209938 DOI: 10.1002/Mrm.27875 |
0.21 |
|
| 2007 |
Fan S, Meng Q, Laterra JJ, Rosen EM. Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage. Oncogene. 26: 4774-96. PMID 17297451 DOI: 10.1038/Sj.Onc.1210271 |
0.207 |
|
| 2017 |
Salas Fragomeni RA, Menke JR, Holdhoff M, Ferrigno C, Laterra JJ, Solnes LB, Javadi MS, Szabo Z, Pomper MG, Rowe SP. Prostate-Specific Membrane Antigen-Targeted Imaging With [18F]DCFPyL in High-Grade Gliomas. Clinical Nuclear Medicine. PMID 28737579 DOI: 10.1097/Rlu.0000000000001769 |
0.206 |
|
| 1996 |
Rao JS, Sawaya R, Gokaslan ZL, Yung WK, Goldstein GW, Laterra J. Modulation of serine proteinases and metalloproteinases during morphogenic glial-endothelial interactions. Journal of Neurochemistry. 66: 1657-64. PMID 8627323 DOI: 10.1046/J.1471-4159.1996.66041657.X |
0.205 |
|
| 1991 |
Guerin C, Laterra J, Hruban RH, Brem H, Drewes LR, Goldstein GW. The glucose transporter and blood-brain barrier of human brain tumors. Annals of Neurology. 28: 758-65. PMID 2178329 DOI: 10.1002/Ana.410280606 |
0.204 |
|
| 2022 |
Zhou J, Zaiss M, Knutsson L, Sun PZ, Ahn SS, Aime S, Bachert P, Blakeley JO, Cai K, Chappell MA, Chen M, Gochberg DF, Goerke S, Heo HY, Jiang S, ... ... Laterra J, et al. Review and consensus recommendations on clinical APT-weighted imaging approaches at 3T: Application to brain tumors. Magnetic Resonance in Medicine. PMID 35452155 DOI: 10.1002/mrm.29241 |
0.199 |
|
| 2001 |
Gao M, Fan S, Goldberg ID, Laterra J, Kitsis RN, Rosen EM. Hepatocyte Growth Factor/Scatter Factor Blocks the Mitochondrial Pathway of Apoptosis Signaling in Breast Cancer Cells Journal of Biological Chemistry. 276: 47257-47265. PMID 11571297 DOI: 10.1074/Jbc.M106791200 |
0.198 |
|
| 2007 |
Zhang Y, Bressler JP, Neal J, Lal B, Bhang HE, Laterra J, Pomper MG. ABCG2/BCRP expression modulates D-Luciferin based bioluminescence imaging. Cancer Research. 67: 9389-97. PMID 17909048 DOI: 10.1158/0008-5472.Can-07-0944 |
0.187 |
|
| 2020 |
Luechtefeld T, Lin N, Paller C, Kuhns K, Laterra JJ, Bressler JP. Measuring Cancer Hallmark Mediation of the TET1 Glioma Survival Effect with Linked Neural-Network Based Mediation Experiments. Scientific Reports. 10: 8886. PMID 32483272 DOI: 10.1038/S41598-020-65369-3 |
0.185 |
|
| 2021 |
Hu C, Wang K, Damon C, Fu Y, Ma T, Kratz L, Lal B, Ying M, Xia S, Cahill DP, Jackson CM, Lim M, Laterra J, Li Y. ATRX loss promotes immunosuppressive mechanisms in IDH1 mutant glioma. Neuro-Oncology. PMID 34951647 DOI: 10.1093/neuonc/noab292 |
0.183 |
|
| 2004 |
Laterra JJ, Grossman SA, Carson KA, Lesser GJ, Hochberg FH, Gilbert MR. Suramin and radiotherapy in newly diagnosed glioblastoma: phase 2 NABTT CNS Consortium study. Neuro-Oncology. 6: 15-20. PMID 14769135 DOI: 10.1215/S1152851703000127 |
0.182 |
|
| 2023 |
Lal B, Kulkarni A, McDermott J, Rais R, Alt J, Wu Y, Lopez-Bertoni H, Sall S, Kathad U, Zhou J, Slusher BS, Bhatia K, Laterra J. Preclinical efficacy of LP-184, a tumor site activated synthetic lethal therapeutic, in glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 37494541 DOI: 10.1158/1078-0432.CCR-23-0673 |
0.182 |
|
| 1983 |
Laterra J, Norton EK, Izzard CS, Culp LA. Contact formation by fibroblasts adhering to heparan sulfate-binding substrata (fibronectin or platelet factor 4). Experimental Cell Research. 146: 15-27. PMID 6222912 DOI: 10.1016/0014-4827(83)90320-8 |
0.179 |
|
| 2023 |
Huang Q, Wu J, Le N, Shen Y, Guo P, Schreck KC, Kamson D, Blair L, Heo HY, Li X, Li W, Sair HL, Blakeley JO, Laterra J, Holdhoff M, et al. CEST2022: Amide proton transfer-weighted MRI improves the diagnostic performance of multiparametric non-contrast-enhanced MRI techniques in patients with post-treatment high-grade gliomas. Magnetic Resonance Imaging. PMID 37321378 DOI: 10.1016/j.mri.2023.06.003 |
0.179 |
|
| 2021 |
Smith-Cohn MA, Abdullaev Z, Aldape KD, Quezado M, Rosenblum MK, Vanderbilt CM, Rodriguez FJ, Laterra J, Eberhart CG. Molecular clarification of brainstem astroblastoma with EWSR1-BEND2 fusion in a 38-year-old man. Free Neuropathology. 2. PMID 37284624 DOI: 10.17879/freeneuropathology-2021-3334 |
0.174 |
|
| 2006 |
Russell JC, Szuflita N, Khatri R, Laterra J, Hossain MA. Transgenic expression of human FGF-1 protects against hypoxic-ischemic injury in perinatal brain by intervening at caspase-XIAP signaling cascades. Neurobiology of Disease. 22: 677-90. PMID 16635575 DOI: 10.1016/j.nbd.2006.01.016 |
0.173 |
|
| 1986 |
Culp LA, Laterra J, Lark MW, Beyth RJ, Tobey SL. Heparan sulphate proteoglycan as mediator of some adhesive responses and cytoskeletal reorganization of cells on fibronectin matrices: independent versus cooperative functions. Ciba Foundation Symposium. 124: 158-83. PMID 2949946 DOI: 10.1002/9780470513385.CH10 |
0.172 |
|
| 2008 |
Lin S, Tsai H, Vescovi A, Laterra J, DeWeese T, Baylin S. The Efficacy of Low Dose Epigenetic Agents in Combination with Ionizing Radiation in a Neurosphere Tumor Model of Glioblastoma Multiforme International Journal of Radiation Oncology*Biology*Physics. 72: S708. DOI: 10.1016/J.Ijrobp.2008.06.537 |
0.172 |
|
| 2014 |
Hong X, Liu L, Wang M, Ding K, Fan Y, Ma B, Lal B, Tyler B, Mangraviti A, Wang S, Wong J, Laterra J, Zhou J. Quantitative multiparametric MRI assessment of glioma response to radiotherapy in a rat model. Neuro-Oncology. 16: 856-67. PMID 24366911 DOI: 10.1093/Neuonc/Not245 |
0.165 |
|
| 2022 |
Jiang S, Guo P, Heo HY, Zhang Y, Wu J, Jin Y, Laterra J, Eberhart CG, Lim M, Blakeley JO. Radiomics analysis of amide proton transfer-weighted and structural MR images for treatment response assessment in malignant gliomas. Nmr in Biomedicine. e4824. PMID 36057449 DOI: 10.1002/nbm.4824 |
0.163 |
|
| 2015 |
Xu X, Yadav NN, Knutsson L, Hua J, Kalyani R, Hall E, Laterra J, Blakeley J, Strowd R, Pomper M, Barker P, Chan K, Liu G, McMahon MT, Stevens RD, et al. Dynamic Glucose-Enhanced (DGE) MRI: Translation to Human Scanning and First Results in Glioma Patients. Tomography : a Journal For Imaging Research. 1: 105-114. PMID 26779568 DOI: 10.18383/j.tom.2015.00175 |
0.162 |
|
| 1994 |
Lal B, Cahan MA, Couraud PO, Goldstein GW, Laterra J. Development of endogenous beta-galactosidase and autofluorescence in rat brain microvessels: implications for cell tracking and gene transfer studies. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 42: 953-6. PMID 8014479 DOI: 10.1177/42.7.8014479 |
0.156 |
|
| 2008 |
Donahue MJ, Blakeley JO, Zhou J, Pomper MG, Laterra J, van Zijl PC. Evaluation of human brain tumor heterogeneity using multiple T1-based MRI signal weighting approaches. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 59: 336-44. PMID 18183606 DOI: 10.1002/Mrm.21467 |
0.152 |
|
| 2016 |
Lopez-Bertoni H, Laterra J. Response letter: “epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells” Translational Cancer Research. 5: S1546-S1548. DOI: 10.21037/tcr.2016.12.29 |
0.15 |
|
| 1994 |
Mankowski JL, Spelman JP, Ressetar HG, Strandberg JD, Laterra J, Carter DL, Clements JE, Zink MC. Neurovirulent simian immunodeficiency virus replicates productively in endothelial cells of the central nervous system in vivo and in vitro. Journal of Virology. 68: 8202-8. PMID 7966612 DOI: 10.1128/Jvi.68.12.8202-8208.1994 |
0.149 |
|
| 2023 |
Douville C, Curtis S, Summers M, Azad TD, Rincon-Torroella J, Wang Y, Mattox A, Avigdor B, Dudley J, Materi J, Raj D, Nair S, Bhanja D, Tuohy K, Dobbyn L, ... ... Laterra J, et al. Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid. Cell Reports. Medicine. 4: 101148. PMID 37552989 DOI: 10.1016/j.xcrm.2023.101148 |
0.138 |
|
| 2021 |
de la Rocha AMA, González-Huarriz M, Guruceaga E, Mihelson N, Tejada-Solís S, Díez-Valle R, Martínez-Vélez N, Fueyo J, Gomez-Manzano C, Alonso MM, Laterra J, López-Bertoni H. Erratum: miR-425-5p, a SOX2 target, regulates the expression of FOXJ3 and RAB31 and promotes the survival of GSCs. Archives of Clinical and Biomedical Research. 5: 425-426. PMID 34888488 DOI: 10.26502/acbr.50170176 |
0.133 |
|
| 2017 |
Hua J, Miao X, Agarwal S, Bettegowda C, Quiñones-Hinojosa A, Laterra J, Van Zijl PCM, Pekar JJ, Pillai JJ. Language Mapping Using T2-Prepared BOLD Functional MRI in the Presence of Large Susceptibility Artifacts-Initial Results in Patients With Brain Tumor and Epilepsy. Tomography : a Journal For Imaging Research. 3: 105-113. PMID 28804779 DOI: 10.18383/j.tom.2017.00006 |
0.133 |
|
| 2015 |
Strowd RE, Salvatori R, Laterra JJ. Temozolomide retreatment in a recurrent prolactin-secreting pituitary adenoma: Hormonal and radiographic response. Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners. 22: 517-22. PMID 25616657 DOI: 10.1177/1078155215569556 |
0.131 |
|
| 2016 |
Lesniak W, Oskolkov N, Song X, Lal B, Yang X, Pomper MG, Laterra J, Nimmagadda S, McMahon MT. Salicylic Acid Conjugated Dendrimers Are a Tunable, High Performance CEST MRI NanoPlatform. Nano Letters. PMID 26910126 DOI: 10.1021/Acs.Nanolett.5B04517 |
0.129 |
|
| 2011 |
Wen PY, Schiff D, Cloughesy TF, Raizer JJ, Laterra J, Smitt M, Wolf M, Oliner KS, Anderson A, Zhu M, Loh E, Reardon DA. A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma. Neuro-Oncology. 13: 437-46. PMID 21297127 DOI: 10.1093/neuonc/noq198 |
0.121 |
|
| 2018 |
Jiang S, Eberhart CG, Lim M, Heo HY, Zhang Y, Blair L, Wen Z, Holdhoff M, Lin D, Huang P, Qin H, Quiñones-Hinojosa A, Weingart J, Barker P, Pomper MG, ... Laterra J, et al. Identifying Recurrent Malignant Glioma after Treatment Using Amide Proton Transfer-Weighted MR Imaging: A Validation Study with Image-Guided Stereotactic Biopsy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30366937 DOI: 10.1158/1078-0432.Ccr-18-1233 |
0.114 |
|
| 2018 |
Shen CJ, Kummerlowe MN, Redmond KJ, Martinez-Gutierrez JC, Usama SM, Holdhoff M, Grossman SA, Laterra JJ, Strowd RE, Kleinberg LR. Re-irradiation for malignant glioma: Toward patient selection and defining treatment parameters for salvage. Advances in Radiation Oncology. 3: 582-590. PMID 30370358 DOI: 10.1016/j.adro.2018.06.005 |
0.11 |
|
| 2004 |
Hossain MA, Russell JC, O'Brien R, Laterra J. Neuronal pentraxin 1: a novel mediator of hypoxic-ischemic injury in neonatal brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 4187-96. PMID 15115814 DOI: 10.1523/Jneurosci.0347-04.2004 |
0.104 |
|
| 2017 |
Jiang S, Eberhart CG, Zhang Y, Heo HY, Wen Z, Blair L, Qin H, Lim M, Quinones-Hinojosa A, Weingart JD, Barker PB, Pomper MG, Laterra J, van Zijl PCM, Blakeley JO, et al. Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas. European Journal of Cancer (Oxford, England : 1990). 83: 9-18. PMID 28704644 DOI: 10.1016/J.Ejca.2017.06.009 |
0.098 |
|
| 2015 |
Khattab MH, Marciscano AE, Lo SS, Lim M, Laterra JJ, Kleinberg LR, Redmond KJ. Antiangiogenic Therapies and Extracranial Metastasis in Glioblastoma: A Case Report and Review of the Literature. Case Reports in Oncological Medicine. 2015: 431819. PMID 26199775 DOI: 10.1155/2015/431819 |
0.081 |
|
| 2021 |
Lopez-Bertoni H, Laterra J. Opinion: miRNAs - The new wave of molecular cancer therapeutics. Translational Oncology. 14: 101064. PMID 33721829 DOI: 10.1016/j.tranon.2021.101064 |
0.077 |
|
| 2017 |
Nabors B, Laterra J. Neuro-Oncology: Current Concepts and Emerging Therapeutics. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 28397114 DOI: 10.1007/s13311-017-0529-8 |
0.062 |
|
| 2015 |
Boer VO, Klomp DW, Laterra J, Barker PB. Parallel reconstruction in accelerated multivoxel MR spectroscopy. Magnetic Resonance in Medicine. 74: 599-606. PMID 26151840 DOI: 10.1002/mrm.25718 |
0.052 |
|
| 2016 |
Lukas RV, Wainwright DA, Laterra JJ. Updates from the Neuro-Oncology Section of the 2015 American Neurological Association Annual Meeting. Future Oncology (London, England). 12: 143-7. PMID 26616737 DOI: 10.2217/Fon.15.299 |
0.047 |
|
| 2010 |
Bressler J, Laterra J. Hood lab investigation. Science (New York, N.Y.). 254: 1091. PMID 17776395 DOI: 10.1126/SCIENCE.254.5035.1091 |
0.026 |
|
| 1978 |
Cashore WJ, Horwich A, Laterra J, Oh W. Effect of postnatal age and clinical status of newborn infants on bilirubin-binding capacity. Biology of the Neonate. 32: 304-9. PMID 610767 DOI: 10.1159/000241033 |
0.02 |
|
| 2002 |
Laterra JJ. PRACTICAL NEURO-ONCOLOGY: A GUIDE TO PATIENT CARE Neuro-Oncology. 4: 302-303. DOI: 10.1093/NEUONC/4.4.302 |
0.016 |
|
| Hide low-probability matches. |